JACS vs Scientific Reports: When Chemistry Needs Selectivity

JACS wants chemistry that changes how chemists make molecules. Not just a new route to a known target, but a fundamentally new transformation or mechanism.

This requires:

• Mechanistic novelty (genuinely new reactivity, not just substrate variation)

• Mechanistic depth (NMR of intermediates, kinetics, computational support explaining why it works)

• Broad substrate scope (showing generality, not optimizing a single example)

• Practical utility (chemists will actually use this method)

• Clean reproducibility (high yields, clean reactions, reliable conditions)

• Clear presentation (JACS papers are read by chemists across all subfields, the story needs to be accessible beyond your specific area)

A paper can have all of these and still get rejected if the novelty is incremental. JACS editors read thousands of papers. Incremental improvements on established reactions get desk rejected quickly.

Scientific Reports wants well-characterized chemistry with complete experimental support.

This requires:

• Clear methods (complete procedures, reagent sources, exact conditions)

• Complete characterization (spectra, melting points, optical rotations as relevant)

• Appropriate scope (even if limited, explain the scope boundaries)

• Reproducibility (your reaction should be repeatable from what you've written)

Novelty is irrelevant. An application of an existing method to new substrates, if done carefully with appropriate controls, is publishable.

Here's the filter: Is your chemistry surprising?

If the reaction shouldn't work based on existing knowledge of reactivity, and you explain why it does, that's JACS material.

If the reaction does what existing chemistry predicts, even if it's optimized nicely, that's more Scientific Reports territory.

Example: A catalytic coupling reaction that works at room temperature with no inert atmosphere, contrary to existing understanding of the mechanism. You then investigate why (alternative pathway discovered). That's mechanistic novelty.

Example: A known coupling reaction applied to a new substrate class using optimized conditions. Methodologically solid, possibly useful, but not mechanistically novel. Scientific Reports, not JACS.

JACS: No mandatory OA. You can publish subscription-based at no cost. Open access option available but not required.

Scientific Reports: $2,850 mandatory OA (unless Springer Nature institutional agreement covers it).

JACS: the ACS author guidelines give no first-decision time.

Scientific Reports: Nature Portfolio's 2025 metrics list a median of 12 days to first editorial decision and 138 days to acceptance.

JACS is cheaper if you don't choose open access. But that only matters if your paper belongs at JACS in the first place.

Try JACS if:

• Your reaction is a fundamentally new transformation (new bond type, new mechanism, new catalytic mode)

• You have mechanistic data explaining why it works

• You've demonstrated broad substrate scope with mechanistic explanation

• You can show this opens possibilities for other chemists

Go to Scientific Reports if:

• Your chemistry is methodologically excellent but incremental

• You've optimized an existing method or applied a known reaction to new substrates

• You're more confident about rigor than novelty

• You want the fastest path to publication (relatively speaking)

JACS rejection rate is commonly estimated at 92% (the ACS author guidelines give no rate). If you get desk rejected, the most common reasons are:

• Incremental chemistry (variation on known reactions)

• Insufficient mechanistic investigation

• Limited substrate scope presented without explanation

Before submitting to Scientific Reports, consider:

1. Is there additional mechanistic data that would help?

1. Can you investigate the scope boundaries more thoroughly?

1. Is there a better mechanistic story to tell?

If the answer is no to all three, and you're genuinely solid on methodology, Scientific Reports is appropriate.

The cost difference is worth noting: JACS lets you publish at $0 behind the subscription paywall if you do not choose an open access option. Scientific Reports requires $2,850 OA APC for every paper. For budget-constrained labs, JACS is actually cheaper, if your chemistry is novel enough to get in. JACS Au ($3,500 APC) is the OA alternative within the ACS family for chemistry that's strong but below JACS's bar.

For context on where these two sit relative to alternatives:

JACS is commonly estimated to reject 92% of submissions (the ACS author guidelines give no rate). If you're among the 92%, the question is what to do next.

If desk-rejected for scope: Your chemistry may be solid but outside JACS's scope (too applied, too materials-focused, not enough mechanism). Consider ACS Catalysis JIF 13.6, ACS Nano JIF 17.3, or Chemistry of Materials JIF 7.1 within ACS. Scientific Reports is appropriate if the work is methodologically sound but the novelty argument doesn't work at any selective venue.

If rejected after review for insufficient novelty: The reviewers saw your work and said it's incremental. Adding more experiments won't fix this, the chemistry itself needs to be more surprising. Consider whether a specialty ACS journal (J. Org. Chem., Inorg. Chem., J. Phys. Chem.) is the right home, or whether Scientific Reports is the pragmatic path to publication.

If rejected for incomplete mechanism: This is the most recoverable rejection. The reviewers want more mechanistic data (kinetics, isotope labeling, computational support, intermediate characterization). Investing 2-3 months in mechanistic experiments and resubmitting to JACS can work. Don't downgrade to Scientific Reports if the mechanism gap is addressable.

Want to know whether your chemistry paper has the mechanistic depth JACS expects? A JACS vs. Scientific Reports scope check assesses novelty framing, scope, and readiness for selective chemistry journals.